• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床康复的人类白细胞抗原-DR17阳性结节病患者的活动标志物。

Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients.

作者信息

Planck A, Eklund A, Grunewald J

机构信息

Dept of Respiratory Medicine, Karolinska Hospital, Stockholm, Sweden.

出版信息

Eur Respir J. 2003 Jan;21(1):52-7. doi: 10.1183/09031936.03.00059103.

DOI:10.1183/09031936.03.00059103
PMID:12570109
Abstract

Scandinavian human leukocyte antigen-DR17-positive (DR17+) sarcoidosis patients are characterised by a good prognosis. They also reveal an accumulation in bronchoalveolar lavage fluid of T-lymphocytes expressing the T-cell receptor V gene segment AV2S3 at disease onset. The authors of this study wished to establish whether AV2S3 T-lymphocyte accumulation changes from disease onset to clinically resolved disease and how this relates to other activity parameters. Bronchoalveolar lavage fluid and serum from nine DR17+ sarcoidosis patients were examined at disease onset and after spontaneous resolution of clinical and radiographical signs of disease. Nine DR17+ patients with lung accumulated CD4+ AV2S3+ T-cells were investigated after clinically recovery. At re-examination the percentage of CD4+ AV2S3+ lymphocytes in bronchoalveolar lavage fluid was normalised (29 versus 5.4%). A significant reduction in lymphocyte percentage (14 versus 4.4%) and a decrease in cellular concentration (179x10(6) x L(-1) versus 111x10(6) x L(-1)) and CD4/CD8 ratio (5.2 versus 2.4) were also seen. In serum, the activity of angiotensin-converting enzyme (24.9 versus 14.0 U x mL(-1)) as well as the levels of neopterin (7.8 versus 5.3 nmol x L(-1)) decreased significantly after recovery. These results indicate that the locally accumulated AV2S3 positive T-lymphocytes in bronchoalveolar lavage are involved in the pathogenic process of sarcoidosis in this patient group.

摘要

斯堪的纳维亚人类白细胞抗原-DR17阳性(DR17+)结节病患者的特点是预后良好。他们还显示,在疾病发作时,表达T细胞受体V基因片段AV2S3的T淋巴细胞在支气管肺泡灌洗液中积聚。本研究的作者希望确定从疾病发作到临床治愈,AV2S3 T淋巴细胞的积聚是否发生变化,以及这与其他活动参数有何关系。在疾病发作时以及临床和影像学症状自发缓解后,对9名DR17+结节病患者的支气管肺泡灌洗液和血清进行了检查。对9名临床康复后肺部积聚CD4+ AV2S3+ T细胞的DR17+患者进行了调查。复查时,支气管肺泡灌洗液中CD4+ AV2S3+淋巴细胞的百分比恢复正常(29%对5.4%)。淋巴细胞百分比也显著降低(14%对4.4%),细胞浓度降低(179×10⁶×L⁻¹对111×10⁶×L⁻¹),CD4/CD8比值降低(5.2对2.4)。血清中,恢复后血管紧张素转换酶活性(24.9对14.0 U×mL⁻¹)以及新蝶呤水平(7.8对5.3 nmol×L⁻¹)显著降低。这些结果表明,支气管肺泡灌洗液中局部积聚的AV2S3阳性T淋巴细胞参与了该患者组结节病的致病过程。

相似文献

1
Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients.临床康复的人类白细胞抗原-DR17阳性结节病患者的活动标志物。
Eur Respir J. 2003 Jan;21(1):52-7. doi: 10.1183/09031936.03.00059103.
2
Inflammatory BAL-fluid and serum parameters in HLA DR17 positive vs. DR17 negative patients with pulmonary sarcoidosis.HLA DR17阳性与DR17阴性肺结节病患者的炎性支气管肺泡灌洗液及血清参数
Sarcoidosis Vasc Diffuse Lung Dis. 2001 Mar;18(1):64-9.
3
Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis.表达T细胞受体AV2S3的肺辅助性T细胞与结节病的临床特征相关。
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):814-8. doi: 10.1164/ajrccm.161.3.9906001.
4
Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation.在具有共同HLA - DRβ链构象的结节病患者中,肺部受限的T细胞受体AV2S3⁺ CD4⁺ T细胞扩增。
Thorax. 2002 Apr;57(4):348-52. doi: 10.1136/thorax.57.4.348.
5
Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis.肺结节病中高度活化的T细胞受体AV2S3(+) CD4(+)肺T细胞扩增。
Am J Respir Crit Care Med. 2001 Jun;163(7):1540-5. doi: 10.1164/ajrccm.163.7.2005028.
6
Prognostic value of Ia+ T lymphocytes in bronchoalveolar lavage fluid in pulmonary sarcoidosis.肺结节病支气管肺泡灌洗液中Ia + T淋巴细胞的预后价值。
Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):707-12. doi: 10.1164/ajrccm.154.3.8810609.
7
T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis.HLA-DR17阳性的活动期和临床康复期结节病患者的T淋巴细胞活性
Sarcoidosis Vasc Diffuse Lung Dis. 2003 Jun;20(2):110-7.
8
[Studies of T-lymphocytes in pursuit of sarcoidosis antigens].[对结节病抗原的T淋巴细胞研究]
Lakartidningen. 2002 Sep 5;99(36):3508-13, 3515.
9
Activated CD8+ T cells and natural killer T cells in bronchoalveolar lavage fluid in hypersensitivity pneumonitis and sarcoidosis.过敏性肺炎和结节病患者支气管肺泡灌洗液中的活化CD8 + T细胞和自然杀伤T细胞。
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):316-24.
10
T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis--indication for an airborne antigen as the triggering factor in sarcoidosis.肺结节病支气管肺泡灌洗液、血液和淋巴结中的 T 细胞表型——提示空气传播抗原是结节病的触发因素。
J Intern Med. 2012 Nov;272(5):465-71. doi: 10.1111/j.1365-2796.2012.02543.x. Epub 2012 May 12.

引用本文的文献

1
Genetically Predicted Leucine Level Mediates Association Between CD4/CD8br T Lymphocytes and Insomnia.基因预测的亮氨酸水平介导CD4/CD8br T淋巴细胞与失眠之间的关联。
Cell Mol Neurobiol. 2025 Jan 22;45(1):15. doi: 10.1007/s10571-025-01533-5.
2
Lymphopenia and high Ki-67 expression in peripheral blood CD4+ and CD8+ T cells associate with progressive sarcoidosis.外周血 CD4+和 CD8+T 细胞中的淋巴细胞减少和 Ki-67 高表达与进行性结节病相关。
BMJ Open Respir Res. 2023 Dec 14;10(1):e001551. doi: 10.1136/bmjresp-2022-001551.
3
Individuals With Higher CD4/CD8 Ratio Exhibit Increased Risk of Acute Respiratory Distress Syndrome and In-Hospital Mortality During Acute SARS-CoV-2 Infection.
CD4/CD8比值较高的个体在急性SARS-CoV-2感染期间发生急性呼吸窘迫综合征和院内死亡的风险增加。
Front Med (Lausanne). 2022 Jun 23;9:924267. doi: 10.3389/fmed.2022.924267. eCollection 2022.
4
The Role of Serum Galectin-3 Levels in Patients with Sarcoidosis.血清半乳糖凝集素-3 水平在结节病患者中的作用。
Med Princ Pract. 2022;31(1):59-65. doi: 10.1159/000521467. Epub 2021 Dec 16.
5
T cell receptor sequencing in autoimmunity.自身免疫中的T细胞受体测序
J Life Sci (Westlake Village). 2020 Dec;2(4):38-58. doi: 10.36069/jols/20201203.
6
Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis.结节病治疗中使用英夫利昔单抗相关的肺免疫细胞变化与临床结局的关系。
Clin Exp Immunol. 2020 Jul;201(1):85-93. doi: 10.1111/cei.13438. Epub 2020 Apr 22.
7
Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.肺结节病和慢性铍病中的适应性免疫。
Front Immunol. 2020 Mar 18;11:474. doi: 10.3389/fimmu.2020.00474. eCollection 2020.
8
High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells.新诊断结节病的高强度抗阻训练——对肺功能、肌肉力量、疲劳、呼吸困难、健康相关生活质量和肺免疫细胞影响的探索性研究
Eur Clin Respir J. 2020 Feb 21;7(1):1730137. doi: 10.1080/20018525.2020.1730137. eCollection 2020.
9
Lung CD4+ Vα2.3+ T-cells in sarcoidosis cohorts with Löfgren's syndrome.结节病伴 Löfgren 综合征患者肺脏 CD4+ Vα2.3+ T 细胞。
Respir Res. 2020 Feb 28;21(1):61. doi: 10.1186/s12931-020-1327-0.
10
Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis.支气管肺泡灌洗液中的细胞亚群可预测结节病的预后。
Eur Respir J. 2020 Jan 30;55(1). doi: 10.1183/13993003.01450-2019. Print 2020 Jan.